Citigroup’s Athenahealth, Inc. ATHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-15,100
Closed -$1.99M 7976
2018
Q4
$1.99M Buy
15,100
+8,400
+125% +$1.08M ﹤0.01% 2667
2018
Q3
$895K Buy
6,700
+4,100
+158% +$614K ﹤0.01% 3619
2018
Q2
$414K Buy
2,600
+600
+30% +$89K ﹤0.01% 4316
2018
Q1
$286K Sell
2,000
-2,800
-58% -$383K ﹤0.01% 4579
2017
Q4
$639K Buy
4,800
+2,100
+78% +$268K ﹤0.01% 3843
2017
Q3
$336K Buy
2,700
+2,400
+800% +$330K ﹤0.01% 4523
2017
Q2
$42K Sell
300
-300
-50% -$37.5K ﹤0.01% 5908
2017
Q1
$68K Sell
600
-1,200
-67% -$140K ﹤0.01% 5495
2016
Q4
$189K Sell
1,800
-1,200
-40% -$129K ﹤0.01% 5329
2016
Q3
$378K Buy
3,000
+2,500
+500% +$318K ﹤0.01% 4149
2016
Q2
$69K Sell
500
-1,600
-76% -$212K ﹤0.01% 5366
2016
Q1
$291K Buy
2,100
+2,000
+2,000% +$274K ﹤0.01% 4727
2015
Q4
$16K Buy
+100
New +$15.4K ﹤0.01% 6611
2015
Q3
Sell
-200
Closed -$23K 7971
2015
Q2
$23K Buy
+200
New +$23.9K ﹤0.01% 6029
2014
Q1
Sell
-33,200
Closed -$4.46M 7316
2013
Q4
$4.46M Buy
+33,200
New +$4.27M ﹤0.01% 1922

Citigroup's ATHN Position: Q1 2019 in Review

Citigroup sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 333,479 shares — an estimated $44M sold.

Citigroup first reported a position in ATHN in Q2 2013 and held it in 23 quarters. The position peaked at $44M in Q4 2018. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

  • Citigroup reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
  • Citigroup sold 333,479 Athenahealth, Inc. shares in Q1 2019, an estimated $44M.
  • Citigroup first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 23 quarters.
  • Citigroup's Athenahealth, Inc. position peaked at $44M in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on Citigroup's 13F filing for Q1 2019, filed 13 May 2019.